- Home
- IVA vs BHR Comparison
IVA vs BHR Comparison
Compare IVA & BHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVA
- BHR
- Stock Information
- Founded
- IVA 2011
- BHR 2013
- Country
- IVA France
- BHR United States
- Employees
- IVA N/A
- BHR N/A
- Industry
- IVA Biotechnology: Pharmaceutical Preparations
- BHR Real Estate Investment Trusts
- Sector
- IVA Health Care
- BHR Real Estate
- Exchange
- IVA Nasdaq
- BHR Nasdaq
- Market Cap
- IVA 162.8M
- BHR 187.7M
- IPO Year
- IVA 2020
- BHR N/A
- Fundamental
- Price
- IVA $3.22
- BHR $2.22
- Analyst Decision
- IVA Strong Buy
- BHR
- Analyst Count
- IVA 4
- BHR 0
- Target Price
- IVA $13.25
- BHR N/A
- AVG Volume (30 Days)
- IVA 8.7K
- BHR 294.4K
- Earning Date
- IVA 03-26-2025
- BHR 05-07-2025
- Dividend Yield
- IVA N/A
- BHR 8.39%
- EPS Growth
- IVA N/A
- BHR N/A
- EPS
- IVA N/A
- BHR N/A
- Revenue
- IVA $15,243,814.00
- BHR $726,796,000.00
- Revenue This Year
- IVA $18.05
- BHR N/A
- Revenue Next Year
- IVA $46.74
- BHR $3.07
- P/E Ratio
- IVA N/A
- BHR N/A
- Revenue Growth
- IVA N/A
- BHR N/A
- 52 Week Low
- IVA $1.53
- BHR $1.98
- 52 Week High
- IVA $3.98
- BHR $3.95
- Technical
- Relative Strength Index (RSI)
- IVA 50.87
- BHR 28.78
- Support Level
- IVA $2.88
- BHR $2.44
- Resistance Level
- IVA $3.10
- BHR $2.76
- Average True Range (ATR)
- IVA 0.22
- BHR 0.12
- MACD
- IVA -0.01
- BHR -0.06
- Stochastic Oscillator
- IVA 30.37
- BHR 1.32
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
About BHR Braemar Hotels & Resorts Inc.
Braemar Hotels & Resorts Inc is a real estate investment trust company that invests in high revenue per available room, or RevPAR, luxury, upper-upscale and upscale hotels in gateway and resort locations. The firm operates in various U.S. states such as California, Texas, Washington, Philadelphia, Florida, and Illinois as well as Washington, D.C. and St. Thomas, U.S. Virgin Islands. The company operates through its direct hotel investment segment of the hotel lodging industry. Its revenue streams include rooms, food and beverage, and other. The firm's hotels operate under various brands, such as Marriott, Hilton, Courtyard, and, among others.